Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer (POWER)

Clinical Trial ID NCT01627379

PubWeight™ 3.98^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01627379

Top papers